DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
Context:Temozolomide (TMZ) is an alkylating agent and was a first-line chemotherapeutic agent for malignant gliomas. Recently, TMZ has been documented to be effective against atypical pituitary adenomas (APAs) and pituitary carcinomas (PCs).Objective:The clinical and pathological characteristics of...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 98; no. 3; pp. 1130 - 1136 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Oxford University Press
01.03.2013
Copyright by The Endocrine Society Endocrine Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!